All blog items

These particular grant awards will boost evidence-based research into the biological and societal drivers of breast cancer metastasis and mortality and will catalyze the development of potential new treatments.

The CISNET grant will be used to study ways of reducing uterine cancer mortality through primary prevention, screening and treatment approaches.

FDA approved a regenerative medicine based on Louise Markert, M.D., Ph.D.'s,  pioneering work as the only therapy for congenital athymia, a grouping of rare diseases s that are characterized by the lack of a functioning thymus.

Although Black lung cancer patients are more likely to die from their disease than white patients, they have better outcomes than whites when treated with immunotherapies that are now considered the best standard of care.

In a special collection of 17 new papers appearing Wednesday in the journal Nature, an international consortium of more than 250 neuroscientists is describing in unprecedented detail the structure – cell by cell -- of the motor cortex in the mouse, marmoset monkey, and human brains.

The School of Medicine Office for Faculty is now accepting applications for the 2022 Duke Clinical Leadership Program (DCLP)

The High-Risk, High-Reward Research program catalyzes scientific discovery by supporting highly innovative research proposals that, due to their inherent risk, may struggle in the traditional peer-review process despite their transformative potential.

Hilmar Lapp is part of an interdisciplinary, multi-institutional collaboration led by Ohio State that will establish a new field of study called “imageomics” that has the potential to transform biomedical, agriculture and basic biological science.

One day when Carol Deane was an undergraduate biology student at Lake Forest College, a private liberal arts university north of Chicago, she happened to pick up a magazine.  “That was back when they had those Save the Children ads that said, ‘You can save this child for 10 cents a day, or you can turn the page,’” says Deane, who recently completed a six-year tenure as chair of the Duke University School of Medicine Board of Visitors. “Well, I couldn’t turn the page.”

Kafui Dzirasa, MD, PhD, and Cagla Eroglu, PhD, have been named Howard Hughes Medical Institute (HHMI) investigators.